- Home
- BMRN vs DOX Comparison
BMRN vs DOX Comparison
Compare BMRN & DOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BMRN | DOX |
|---|---|---|
| Founded | 1996 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.0B | 8.5B |
| IPO Year | 1999 | 1998 |
Fundamental Metrics
Financial Performance| Metric | BMRN | DOX |
|---|---|---|
| Price | $63.10 | $69.88 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 21 | 4 |
| Target Price | $90.10 | ★ $92.33 |
| AVG Volume (30 Days) | ★ 1.9M | 1.6M |
| Earning Date | 04-22-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.26% |
| EPS Growth | ★ 154.02 | N/A |
| EPS | ★ 2.04 | N/A |
| Revenue | ★ $1,313,646,000.00 | N/A |
| Revenue This Year | $13.53 | $4.46 |
| Revenue Next Year | $10.40 | $3.72 |
| P/E Ratio | $31.09 | ★ $13.65 |
| Revenue Growth | ★ 17.62 | N/A |
| 52 Week Low | $50.76 | $66.53 |
| 52 Week High | $73.51 | $94.61 |
Technical Indicators
Market Signals| Indicator | BMRN | DOX |
|---|---|---|
| Relative Strength Index (RSI) | 72.31 | 34.10 |
| Support Level | $59.38 | $66.53 |
| Resistance Level | $63.75 | $70.85 |
| Average True Range (ATR) | 1.93 | 2.97 |
| MACD | 0.55 | -0.40 |
| Stochastic Oscillator | 94.59 | 22.54 |
Price Performance
Historical ComparisonAbout BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
About DOX Amdocs Limited
Amdocs Ltd is a provider of software and services to communications, cable and satellite, entertainment, and media industry service providers. The Company and its subsidiaries operate in one operating segment, providing software products and services for the communications, entertainment and media industry service being designed, develop, market, support, implement, and operate its open and modular cloud offering. The company offers business support systems, operational support systems, and managed services. Geographically, it derives a majority of revenue from North America and also has a presence in Europe and the Rest of the world.